Inovio Pharmaceuticals Statistics
Total Valuation
INO has a market cap or net worth of $116.07 million. The enterprise value is $66.93 million.
Important Dates
The last earnings date was Thursday, March 12, 2026, after market close.
| Earnings Date | Mar 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INO has 69.09 million shares outstanding. The number of shares has increased by 72.63% in one year.
| Current Share Class | 69.09M |
| Shares Outstanding | 69.09M |
| Shares Change (YoY) | +72.63% |
| Shares Change (QoQ) | +18.91% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 47.85% |
| Float | 68.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,776.39 |
| Forward PS | n/a |
| PB Ratio | 4.81 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1,024.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.40, with a Debt / Equity ratio of 0.39.
| Current Ratio | 1.40 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -183.47% and return on invested capital (ROIC) is -95.34%.
| Return on Equity (ROE) | -183.47% |
| Return on Assets (ROA) | -57.88% |
| Return on Invested Capital (ROIC) | -95.34% |
| Return on Capital Employed (ROCE) | -283.35% |
| Weighted Average Cost of Capital (WACC) | 12.89% |
| Revenue Per Employee | $488 |
| Profits Per Employee | -$633,925 |
| Employee Count | 134 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.24% in the last 52 weeks. The beta is 1.76, so INO's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -17.24% |
| 50-Day Moving Average | 1.65 |
| 200-Day Moving Average | 1.96 |
| Relative Strength Index (RSI) | 47.79 |
| Average Volume (20 Days) | 804,743 |
Short Selling Information
The latest short interest is 10.96 million, so 15.86% of the outstanding shares have been sold short.
| Short Interest | 10.96M |
| Short Previous Month | 11.42M |
| Short % of Shares Out | 15.86% |
| Short % of Float | 15.94% |
| Short Ratio (days to cover) | 10.69 |
Income Statement
In the last 12 months, INO had revenue of $65,343 and -$84.95 million in losses. Loss per share was -$1.81.
| Revenue | 65,343 |
| Gross Profit | -54.14M |
| Operating Income | -86.82M |
| Pretax Income | -84.95M |
| Net Income | -84.95M |
| EBITDA | -85.40M |
| EBIT | -86.82M |
| Loss Per Share | -$1.81 |
Full Income StatementBalance Sheet
The company has $58.51 million in cash and $9.37 million in debt, with a net cash position of $49.14 million or $0.71 per share.
| Cash & Cash Equivalents | 58.51M |
| Total Debt | 9.37M |
| Net Cash | 49.14M |
| Net Cash Per Share | $0.71 |
| Equity (Book Value) | 24.10M |
| Book Value Per Share | 0.35 |
| Working Capital | 17.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$88.63 million and capital expenditures -$285,698, giving a free cash flow of -$88.92 million.
| Operating Cash Flow | -88.63M |
| Capital Expenditures | -285,698 |
| Free Cash Flow | -88.92M |
| FCF Per Share | -$1.29 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -132,871.32% |
| Pretax Margin | -130,000.00% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -72.63% |
| Shareholder Yield | -72.63% |
| Earnings Yield | -73.18% |
| FCF Yield | -76.60% |
Analyst Forecast
The average price target for INO is $9.00, which is 435.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.00 |
| Price Target Difference | 435.71% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 230.98% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 25, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
INO has an Altman Z-Score of -36.64. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -36.64 |
| Piotroski F-Score | n/a |
